High levels of CD4+ are known to be associated with nevirapine-induced liver toxicity [13], and in our cohort of nevirapine-treated women baseline levels of CD4+ > 250/mm3 were indeed correlated to the emergence of grade ≥ 2 ALT elevation. Here, CD4 is linked to toxicity.